유럽의 말초혈관 기기 시장 : 규모, 동향(2023-2029년) : MedSuite

In 2022, the European market for peripheral vascular devices reached a valuation of approximately €1.5 billion. As we look ahead, it is expected to experience a steady growth rate with a projected CAGR of 3.1% during the forecast period, ultimately reaching around €1.9 billion.

Our extensive medical device market research encompassed an analysis of over 50 companies operating within the peripheral vascular device market across Europe. Through our comprehensive methodology, we delved into various aspects including market sizes, unit sales, company market shares, and average sales prices (ASPs) to provide accurate forecasts.

The full report suite on the European peripheral vascular (PV) devices market offers a comprehensive analysis of a wide range of devices including peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy (IVL) systems, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, carotid shunts, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices, and peripheral intravascular ultrasound (IVUS) catheters. Our in-depth analysis provides valuable insights into this dynamic market.

DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Forecasts Until 2029, and Historical Data to 2019
• Market Drivers & Limiters for Each Peripheral Vascular Device market
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

EUROPEAN PERIPHERAL VASCULAR DEVICES MARKET INSIGHTS

The COVID-19 pandemic had a significant impact on the European peripheral vascular (PV) market in 2020. Lockdown measures and procedure delays led to reduced demand and lower sales for PV device companies. However, as restrictions eased and procedures resumed, the PV market started to recover. In 2021 and 2022, there was a noticeable increase in demand for PV devices as postponed procedures were addressed. This recovery demonstrates the resilience of the PV market in Europe.

The IVL (Intravascular Lithotripsy) market in Europe has witnessed significant growth in recent years. This advanced technology employs sound waves to disrupt calcium deposits in arteries, offering a more effective and minimally invasive alternative to conventional treatments for peripheral arterial disease. The escalating prevalence of peripheral artery disease, coupled with the rising demand for less invasive treatment options, has fueled the increasing adoption of IVL in Europe.

EUROPEAN PERIPHERAL VASCULAR DEVICES MARKET SHARE INSIGHTS

In 2022, Medtronic emerged as the leading player in the European PV market, leveraging its strong presence in the stent graft segment and diverse product portfolio. The company's ability to capture significant shares in high-value markets has enabled it to bundle lower-priced products, enhancing its overall market position. Medtronic's flagship offerings, such as Admiral IN.PACT™ drug-coated balloons, Endurant™ and Valiant™ stent grafts, along with a range of stents and PTA balloons, have contributed to substantial revenue generation. Furthermore, Medtronic has established dominance in the atherectomy device market, despite its relatively smaller size in Europe.

Cook Medical secured the second-leading position in the PV market, primarily driven by its strong foothold in the stent graft segment. The company also led the inferior vena cava filter (IVCF) market, although it constitutes a smaller portion of its revenue due to the market's size. Cook Medical's Zenith® family of stent grafts stands out as the company's flagship product, contributing significantly to its overall market presence.

Boston Scientific, following its merger with BTG in 2019, initially secured the second-leading position in the European market. However, in 2022, it slipped to the third position due to market share loss to Cook Medical. Nevertheless, Boston Scientific has made notable progress in its venous treatment and transcatheter embolization portfolios after the acquisition, establishing a leading position in both markets. With a comprehensive portfolio for treating venous diseases, Boston Scientific is expected to gradually regain market share in the overall PV market over time.

RESEARCH REGIONAL COVERAGE

Throughout our research series, iData Research has extensively covered numerous countries, providing in-depth analysis and insights. Some of the countries we have focused on include:

SEGMENTS COVERED

• Peripheral Vascular Stent Market
• PTA Balloon Catheter Market
• Drug-Coated Balloon Market
• Atherectomy Device Market
• Intravascular Lithotripsy Market
• CTO Device Market
• Surgical Graft Market
• Stent Graft Market
• Embolic Protection Device Market
• Peripheral Thrombus Management Market
• Inferior Vena Cava Filter Market
• Carotid Shunt Market
• Diagnostic and Interventional Catheter Market
• Diagnostic and Interventional Guidewire Market
• Introducer Sheath Market
• Vascular Closure Device Market
• Transcatheter Embolization Market
• Peripheral IVUS Market

RESEARCH SCOPE SUMMARY

• Regions: Western Europe, Central & Eastern Europe

• Base Year: 2022

• Forecast: 2023-2029

• Historical Data: 2019-2022

• Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

• Qualitative Coverage: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

TABLE OF CONTENT

• Table of Contents
• List of Figures
• List of Charts

Executive summary

European Peripheral Vascular Device Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Numbers

Markets Included

Key Report Updates

Version History

Research methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems and Perform Secondary Research
• Step 3: Preparation for Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast and Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review and Market Release
• Step 9: Customer Feedback and Market Monitoring

Impact of covid-19 on THE European peripheral vascular device Market

• 2.1. Introduction
• 2.2. Country Profile
• 2.3. Analysis By Market Segment
  • 2.3.1. Worst Case Scenario
  • 2.3.2. Base Case Scenario
  • 2.3.3. Best Case Scenario

Disease Overview

• 3.1. Basic Anatomy
• 3.2. Disease Treatments & Diagnostics
  • 3.2.1. Aortic Aneurysms
  • 3.2.2. Atherosclerosis
  • 3.2.3. Peripheral Arterial Disease (PAD)
  • 3.2.4. Deep Vein Thrombosis
  • 3.2.5. Pulmonary Embolism
• 3.3. Patient Demographics
  • 3.3.1. Aortic Aneurysms
  • 3.3.2. Atherosclerosis
  • 3.3.3. Peripheral Arterial Disease (PAD)
  • 3.3.4. Deep Vein Thrombosis
  • 3.3.5. Pulmonary Embolism

Product Assessment

• 4.1. Introduction
• 4.2. Product Portfolios
  • 4.2.1. Peripheral Vascular Stent
  • 4.2.2. PTA Balloon Catheter
  • 4.2.3. Drug-Coated Balloon
  • 4.2.4. Atherectomy Device
  • 4.2.5. Intravascular Lithotripsy Market
  • 4.2.6. Chronic Total Occlusion
  • 4.2.7. Surgical Graft
  • 4.2.8. Stent Graft
  • 4.2.9. Embolic Protection
  • 4.2.10. Peripheral Thrombus Management
  • 4.2.11. Inferior Vena Cava Filter and Retrieval
  • 4.2.12. Carotid Shunt
  • 4.2.13. Diagnostic and Interventional Catheter
  • 4.2.14. Diagnostic and Interventional Guidewire
  • 4.2.15. Introducer Sheath
  • 4.2.16. Vascular Closure Device
  • 4.2.17. Transcatheter Embolization Device
  • 4.2.18. Peripheral IVUS Catheter
• 4.3. Regulatory Issues and Recalls
  • 4.3.1. Peripheral Vascular Stent
  • 4.3.2. PTA Balloon Catheter
  • 4.3.3. Atherectomy Device
  • 4.3.4. Intravascular Lithotripsy Market
  • 4.3.5. Chronic Total Occlusion
  • 4.3.6. Surgical Graft
  • 4.3.7. Stent Graft
  • 4.3.8. Peripheral Thrombus Management
  • 4.3.9. Peripheral Thrombus Management Devices
  • 4.3.10. Inferior Vena Cava Filter and Retrieval
  • 4.3.11. Diagnostic and Interventional Catheter
  • 4.3.12. Diagnostic and Interventional Guidewire
  • 4.3.13. Introducer Sheath
  • 4.3.14. Transcatheter Embolization Device
  • 4.3.15. Peripheral IVUS Catheter
• 4.4. Clinical Trials
  • 4.4.1. Peripheral Vascular Stent
  • 4.4.2. PTA Balloon Catheter
  • 4.4.3. Drug-Coated Balloon
  • 4.4.4. Atherectomy Device
  • 4.4.5. Intravascular Lithotripsy
  • 4.4.6. Surgical Graft
  • 4.4.7. Stent Graft
  • 4.4.8. Embolic Protection
  • 4.4.9. Peripheral Thrombus Management
  • 4.4.10. Inferior Vena Cava Filter & Retrieval
  • 4.4.11. Vascular Closure Device
  • 4.4.12. Transcatheter Embolization Device

European Peripheral vascular device Market Overview

• 5.1. Introduction
  • 5.1.1. Atherosclerosis
  • 5.1.2. Peripheral Arterial Disease
• 5.2. Currency Exchange Rate
• 5.3. Market Overview & Trend Analysis
• 5.4. Drivers and Limiters
  • 5.4.1. Market Drivers
  • 5.4.2. Market Limiters
• 5.5. Competitive Market Share Analysis
• 5.6. Mergers and Acquisitions
• 5.7. Company Profiles
  • 5.7.1. Abbott
  • 5.7.2. Becton Dickinson
  • 5.7.3. Boston Scientific
  • 5.7.4. Cardinal Health
  • 5.7.5. Cardiovascular Systems, Inc.
  • 5.7.6. Cook Medical
  • 5.7.7. Medtronic
  • 5.7.8. Penumbra
  • 5.7.9. Philips
  • 5.7.10. Shockwave Medical
  • 5.7.11. Silk Road Medical
  • 5.7.12. Terumo
  • 5.7.13. W.L. Gore
• 5.8. SWOT Analysis
  • 5.8.1. Abbott
  • 5.8.2. Becton Dickinson
  • 5.8.3. Boston Scientific
  • 5.8.4. Cardinal Health
  • 5.8.5. Cardiovascular Systems, Inc.
  • 5.8.6. Cook Medical
  • 5.8.7. Medtronic
  • 5.8.8. Penumbra
  • 5.8.9. Philips
  • 5.8.10. Shockwave Medical
  • 5.8.11. Silk Road Medical
  • 5.8.12. Terumo
  • 5.8.13. W.L. Gore

Country Profiles

• 6.1. Introduction
  • 6.1.1. Population
  • 6.1.2. GDP Per Capita
  • 6.1.3. Price Index
• 6.2. Germany
• 6.3. France
• 6.4. United Kingdom
• 6.5. Italy
• 6.6. Spain
• 6.7. Benelux
• 6.8. Scandinavia
• 6.9. Austria
• 6.10. Switzerland
• 6.11. Portugal

Procedure Numbers

• 7.1. Procedures
  • 7.1.1. Peripheral Vascular Stent Procedures
    • 7.1.1.1. Arterial Stent Procedures
    • 7.1.1.1.1. Bare-Metal Stent Procedures
    • 7.1.1.1.2. Covered Stent Procedures
    • 7.1.1.1.3. Drug-Eluting Stent Procedures
    • 7.1.1.2. Venous Stent Procedures
  • 7.1.2. PTA Balloon Catheter Procedures
  • 7.1.3. Drug-Coated Balloon Procedures
  • 7.1.4. Atherectomy Device Procedures
    • 7.1.4.1. Laser Atherectomy Device Procedures
    • 7.1.4.2. Mechanical Atherectomy Device Procedures
  • 7.1.5. Intravascular Lithotripsy Procedures
    • 7.1.5.1. SFA and Iliac Lithotripsy Procedures
    • 7.1.5.2. BTK Lithotripsy Procedures
  • 7.1.6. CTO Device Procedures
    • 7.1.6.1. Re-Entry CTO Procedures
    • 7.1.6.2. Recanalization CTO Procedures
  • 7.1.7. Surgical Graft Procedures
    • 7.1.7.1. Total Surgical Graft Procedures by Material
    • 7.1.7.1.1. Polyester Surgical Graft Procedures
    • 7.1.7.1.2. ePTFE Surgical Graft Procedures
    • 7.1.7.2. Total Surgical Graft Procedures by Indication
    • 7.1.7.2.1. Lower-Limb Surgical Graft Procedures
    • 7.1.7.2.2. AV Access Surgical Graft Procedures
    • 7.1.7.2.3. Aorta Repair Surgical Graft Procedures
    • 7.1.7.2.4. Extra-Anatomical Bypass Surgical Graft Procedures
  • 7.1.8. Stent Graft Procedures
    • 7.1.8.1. AAA Stent Graft Procedures
    • 7.1.8.2. Fenestrated Stent Graft Procedures
    • 7.1.8.3. TAA Stent Graft Procedures
  • 7.1.9. Embolic Protection Device Procedures
    • 7.1.9.1. Carotid EPD Procedures
    • 7.1.9.2. Renal EPD Procedures
    • 7.1.9.3. Lower-Limb EPD Procedures
  • 7.1.10. Peripheral Thrombus Management Procedures
    • 7.1.10.1. Traditional Thrombectomy Device Procedures
    • 7.1.10.2. Pharmacomechanical Thrombectomy Device Procedures
  • 7.1.11. IVCF Placement Procedures
    • 7.1.11.1. Retrievable IVCF Procedures
    • 7.1.11.2. Permanent IVCF Procedures
  • 7.1.12. Carotid Shunt Procedures
  • 7.1.13. Vascular Closure Device Procedures
    • 7.1.13.1. Total Vascular Closure Device Procedures by Device Type
    • 7.1.13.1.1. Small-Bore Invasive VCD Procedures
    • 7.1.13.1.2. Large-Bore Invasive VCD Procedures
    • 7.1.13.1.3. Non-Invasive VCD Procedures
    • 7.1.13.2. Total Vascular Closure Device Procedures by Approach
    • 7.1.13.2.1. Radial VCD Procedures
    • 7.1.13.2.2. Femoral VCD Procedures
  • 7.1.14. Transcatheter Embolization Procedures
    • 7.1.14.1. Particle Embolization Procedures
    • 7.1.14.1.1. PVA Particle Procedures
    • 7.1.14.1.2. Microsphere Procedures
    • 7.1.14.1.3. Drug-Eluting Particle Procedures
    • 7.1.14.1.4. Radioactive Particle Procedures
    • 7.1.14.2. Coil Embolization Procedures
    • 7.1.14.2.1. Pushable Coil Procedures
    • 7.1.14.2.2. Detachable Coil Procedures
    • 7.1.14.3. Liquid Embolics Procedures
    • 7.1.14.4. Plug Embolization Procedures
  • 7.1.15. Peripheral IVUS Procedures

Peripheral Vascular Stent Market

• 8.1. Introduction
  • 8.1.1. Peripheral Arterial Stents
    • 8.1.1.1. Off-Label Use
    • 8.1.1.2. Covered Stents
    • 8.1.1.3. Drug-Eluting Stents
    • 8.1.1.4. Stent Length
  • 8.1.2. Venous Stents
• 8.2. Market Overview
• 8.3. Market Analysis and Forecast
  • 8.3.1. Arterial Stent Market
    • 8.3.1.1. Total Bare-Metal Stent Market
    • 8.3.1.1.1. Bare-Metal Carotid Stent Market
    • 8.3.1.1.2. Bare-Metal Iliac Stent Market
    • 8.3.1.1.3. Bare-Metal Renal Stent Market
    • 8.3.1.1.4. Bare-Metal Fem-Pop Stent Market
    • 8.3.1.1.5. Bare-Metal Infra-Pop Stent Market
    • 8.3.1.2. Covered Stent Market
    • 8.3.1.3. Drug-Eluting Stent Market
  • 8.3.2. Venous Stent Market
• 8.4. Unit Analysis
  • 8.4.1. Bare-Metal Stent Units Sold by Delivery Platform
    • 8.4.1.1. Self-Expanding Bare-Metal Stent Units
    • 8.4.1.2. Balloon-Expanding Bare-Metal Stent Units
  • 8.4.2. Bare-Metal Stent Units Sold by Stent Length
    • 8.4.2.1. Bare-Metal Carotid Stent Units
    • 8.4.2.2. Bare-Metal Iliac Stent Units
    • 8.4.2.3. Bare-Metal Renal Stent Units
    • 8.4.2.4. Bare-Metal Fem-Popliteal Stent Units
  • 8.4.3. Covered Stent Units Sold by Delivery Platform
    • 8.4.3.1. Iliac Covered Stent Units
    • 8.4.3.2. Fem-Pop Covered Stent Units
    • 8.4.3.3. AV Access Covered Stent Units
  • 8.4.4. Drug-Eluting Stent Units Sold by Delivery Platform
    • 8.4.4.1. SFA Drug-Eluting Stent Units
    • 8.4.4.2. Infra-Pop Drug-Eluting Stent Units
• 8.5. Drivers and Limiters
  • 8.5.1. Market Drivers
  • 8.5.2. Market Limiters
• 8.6. Competitive Market Share Analysis

PTA Balloon Catheter Market

• 9.1. Introduction
  • 9.1.1. Types of PTA Balloon Catheters
• 9.2. Market Overview
• 9.3. Market Analysis and Forecast
  • 9.3.1. Total PTA Balloon Catheter Market
  • 9.3.2. Standard PTA Balloon Catheter Market
  • 9.3.3. High-Pressure PTA Balloon Catheter Market
  • 9.3.4. Large PTA Balloon Catheter Market
  • 9.3.5. Small PTA Balloon Catheter Market
  • 9.3.6. Specialty PTA Balloon Catheter Market
• 9.4. Drivers and Limiters
  • 9.4.1. Market Drivers
  • 9.4.2. Market Limiters
• 9.5. Competitive Market Share Analysis

Drug-Coated Balloon Market

• 10.1. Introduction
• 10.2. Market Analysis and Forecast
• 10.3. Drivers and Limiters
  • 10.3.1. Market Drivers
  • 10.3.2. Market Limiters
• 10.4. Competitive Market Share Analysis

Atherectomy Device Market

• 11.1. Introduction
• 11.2. Market Overview
• 11.3. Market Analysis and Forecast
  • 11.3.1. Total Atherectomy Device Market
  • 11.3.2. Laser Atherectomy Device Market
  • 11.3.3. Mechanical Atherectomy Device Market
• 11.4. Drivers and Limiters
  • 11.4.1. Market Drivers
  • 11.4.2. Market Limiters
• 11.5. Competitive Market Share Analysis

Intravascular lithotripsy Market

• 12.1. Introduction
• 12.2. Market Analysis and Forecast
• 12.3. Drivers and Limiters
  • 12.3.1. Market Drivers
  • 12.3.2. Market Limiters
• 12.4. Competitive Market Share Analysis

Chronic total occlusion device Market

• 13.1. Introduction
• 13.2. Market Overview
• 13.3. Market Analysis and Forecast
  • 13.3.1. Total CTO Device Market
  • 13.3.2. Re-Entry Device Market
  • 13.3.3. Recanalization Device Market
• 13.4. Drivers and Limiters
  • 13.4.1. Market Drivers
  • 13.4.2. Market Limiters
• 13.5. Competitive Market Share Analysis

Surgical Graft Market

• 14.1. Introduction
• 14.2. Market Overview
• 14.3. Market Analysis and Forecast
  • 14.3.1. Total Lower-Limb Surgical Graft Market
    • 14.3.1.1. Above-the-Knee Surgical Graft Market
    • 14.3.1.2. Below-the-Knee Surgical Graft Market
  • 14.3.2. AV Access Surgical Graft Market
  • 14.3.3. Total Aorta Repair Surgical Graft Market
    • 14.3.3.1. Abdominal Aortic Aneurysm Surgical Graft Market
    • 14.3.3.2. Thoracic Aortic Aneurysm Surgical Graft Market
  • 14.3.4. Extra-Anatomical Bypass Surgical Graft Market
• 14.4. Unit Analysis
  • 14.4.1. Surgical Graft Units Sold by Material
    • 14.4.1.1. Polyester Surgical Graft Units
    • 14.4.1.2. ePTFE Surgical Graft Units
• 14.5. Drivers and Limiters
  • 14.5.1. Market Drivers
  • 14.5.2. Market Limiters
• 14.6. Competitive Market Share Analysis

Stent graft Market

• 15.1. Introduction
• 15.2. Market Overview
• 15.3. Market Analysis and Forecast
  • 15.3.1. Total Stent Graft Market
  • 15.3.2. AAA Stent Graft Market
  • 15.3.3. TAA Stent Graft Market
  • 15.3.4. Fenestrated Stent Graft Market
• 15.4. Drivers and Limiters
  • 15.4.1. Market Drivers
  • 15.4.2. Market Limiters
• 15.5. Competitive Market Share Analysis

Embolic Protection Device Market

• 16.1. Introduction
  • 16.1.1. Protection Mechanism
    • 16.1.1.1. Filter Basket
    • 16.1.1.2. Distal Balloon Occlusion
    • 16.1.1.3. Flow Redirection
• 16.2. Market Overview
• 16.3. Market Analysis and Forecast
  • 16.3.1. Total Embolic Protection Device Market
  • 16.3.2. Carotid Embolic Protection Device Market
  • 16.3.3. Renal Embolic Protection Device Market
  • 16.3.4. Lower-Limb Embolic Protection Device Market
• 16.4. Drivers and Limiters
  • 16.4.1. Market Drivers
  • 16.4.2. Market Limiters
• 16.5. Competitive Market Share Analysis

Peripheral Thrombus Management Market

• 17.1. Introduction
  • 17.1.1. AV Access Thrombectomy Devices
  • 17.1.2. Other Peripheral Applications of Thrombectomy Devices
• 17.2. Market Overview
• 17.3. Market Analysis and Forecast
  • 17.3.1. Total Peripheral Thrombus Management Market
  • 17.3.2. Traditional Thrombectomy Device Market
  • 17.3.3. Pharmacomechanical Thrombectomy Device Market
• 17.4. Drivers and Limiters
  • 17.4.1. Market Drivers
  • 17.4.2. Market Limiters
• 17.5. Competitive Market Share Analysis

Inferior vena cava filter Market

• 18.1. Introduction
• 18.2. Market Overview
• 18.3. Market Analysis and Forecast
  • 18.3.1. Total Inferior Vena Cava Filter Market
  • 18.3.2. Retrievable IVCF Market
  • 18.3.3. Permanent IVCF Market
• 18.4. Drivers and Limiters
  • 18.4.1. Market Drivers
  • 18.4.2. Market Limiters
• 18.5. Competitive Market Share Analysis

Carotid shunt Market

• 19.1. Introduction
• 19.2. Market Analysis and Forecast
• 19.3. Drivers and Limiters
  • 19.3.1. Market Drivers
  • 19.3.2. Market Limiters
• 19.4. Competitive Market Share Analysis

Diagnostic and Interventional Catheter Market

• 20.1. Introduction
• 20.2. Market Overview
• 20.3. Market Analysis and Forecast
  • 20.3.1. Total Diagnostic and Interventional Catheter Market
  • 20.3.2. Total Diagnostic Catheter Market
    • 20.3.2.1. Standard Diagnostic Catheter Market
    • 20.3.2.2. Hydrophilic Diagnostic Catheter Market
  • 20.3.3. Support Catheter Market
• 20.4. Drivers and Limiters
  • 20.4.1. Market Drivers
  • 20.4.2. Market Limiters
• 20.5. Competitive Market Share Analysis

Diagnostic and interventional guidewire Market

• 21.1. Introduction
• 21.2. Market Overview
• 21.3. Market Analysis and Forecast
  • 21.3.1. Total Diagnostic and Interventional Guidewire Market
  • 21.3.2. Standard Guidewire Market
  • 21.3.3. Hydrophilic Guidewire Market
• 21.4. Drivers and Limiters
  • 21.4.1. Market Drivers
  • 21.4.2. Market Limiters
• 21.5. Competitive Market Share Analysis

Introducer sheath Market

• 22.1. Introduction
• 22.2. Market Overview
• 22.3. Market Analysis and Forecast
  • 22.3.1. Total Introducer Sheath Market
  • 22.3.2. Standard Introducer Sheath Market
  • 22.3.3. Guiding Introducer Sheath Market
• 22.4. Drivers and Limiters
  • 22.4.1. Market Drivers
  • 22.4.2. Market Limiters
• 22.5. Competitive Market Share Analysis

Vascular Closure Device Market

• 23.1. Introduction
• 23.2. Market Overview
  • 23.2.1. Vascular Closure Device Market Overview by Device Type
  • 23.2.2. Vascular Closure Device Market Overview by Approach
• 23.3. Market Analysis and Forecast
  • 23.3.1. Total Vascular Closure Device Market by Device Type
    • 23.3.1.1. Total Invasive Vascular Closure Device Market
    • 23.3.1.1.1. Small-Bore Vascular Closure Device Market
    • 23.3.1.1.2. Large-Bore Vascular Closure Device Market
    • 23.3.1.2. Non-Invasive Vascular Closure Device Market
  • 23.3.2. Total Vascular Closure Device Market by Approach
    • 23.3.2.1. Radial Vascular Closure Device Market
    • 23.3.2.2. Femoral Vascular Closure Device Market
• 23.4. Drivers and Limiters
  • 23.4.1. Market Drivers
  • 23.4.2. Market Limiters
• 23.5. Competitive Market Share Analysis

Transcatheter Embolization Market

• 24.1. Introduction
  • 24.1.1. Particle Embolic Devices
  • 24.1.2. Coil Embolic Devices
  • 24.1.3. Liquid Embolic Devices
  • 24.1.4. Vascular Plugs
• 24.2. Market Overview
• 24.3. Market Analysis and Forecast
  • 24.3.1. Particle Embolization Market
    • 24.3.1.1. PVA Particle Market
    • 24.3.1.2. Microsphere Market
    • 24.3.1.3. Drug-Eluting Particle Market
    • 24.3.1.4. Radioactive Particle Market
  • 24.3.2. Coil Embolization Market
    • 24.3.2.1. Pushable Coil Market
    • 24.3.2.2. Detachable Coil Market
  • 24.3.3. Liquid Embolization Market
  • 24.3.4. Plug Embolization Market
• 24.4. Drivers and Limiters
  • 24.4.1. Market Drivers
  • 24.4.2. Market Limiters
• 24.5. Competitive Market Share Analysis

Peripheral ivus Market

• 25.1. Introduction
• 25.2. Market Analysis and Forecast
• 25.3. Drivers and Limiters
  • 25.3.1. Market Drivers
  • 25.3.2. Market Limiters
• 25.4. Competitive Market Share Analysis

Abbreviations